Lutropin Alfa in Women at Risk of Poor Response

Clinical trial NCT01112358 · COMPLETED

Trial details

NCT number: NCT01112358
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Stimulation

Start date: 2005-12-07
Primary completion: 2007-01-30
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.